AzTrials
AzTrials

Depressive SymptomsNCT05482646

Tai Chi Versus Conventional Exercise to Alleviate Depression in Insomniacs

A study testing Tai Chi and Conventional exercise in people with Depressive Symptoms and Chronic Insomnia, run by The University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the effectiveness of Tai Chi and conventional exercise in alleviating depressive symptoms in older insomniacs. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Depressive Symptoms, Chronic Insomnia
What is being tested?
Tai Chi and Conventional exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
420 participants
Where
1 siteHong Kong
Study dates
2 Aug 2022to 28 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 60 years or older
  • Can communicate using Cantonese or Mandarin
  • with mild-to-moderate depressive symptoms (HADS-depression score ≥8/21 and PHQ- 9 score ≤14/27)
  • Fulfil the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for chronic insomnia including difficulties in initiating or maintaining sleep, early morning awakening with complaint of significant distress or impairment of daytime functioning, sleep difficulty occurring at least three nights per week and present for at least 3 months.

Who cannot join

  • Somatic condition that prevents participation in tai chi or exercise
  • Regular moderate-to-vigorous intensity exercise or mind-body training such as tai chi, yoga, qigong or meditation in the past 3 months
  • Any form (or combination) of exercises amounting to 180 minutes per week in the past 3 months
  • Dementia
  • Diagnosis with schizophrenia or other psychotic disorders, bipolar disorders or alcohol/substance use/abuse
  • Current usage or planning to use potentially confounding treatments, including herbal supplementations (e.g., St. John's Wort), acupuncture treatment, cognitive behavioral therapy or other psychotherapy, mind-body intervention (e.g., mindfulness training and muscle relaxation training) or muscle relaxants such as carisoprodol, cyclobenzaprine, diazepam
  • Current suicidal or self-injurious potential that requires immediate clinical follow-up.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • LKS Faculty of Medicine, HKU

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Tai Chi Versus Conventional Exercise to Alleviate Depressive Symptoms in Older Insomniacs: A Three-arm Randomized Controlled Trial

This study aims to examine the effectiveness of Tai Chi and conventional exercise in alleviating depressive symptoms in older insomniacs.

Read the detailed description

Chinese community-dwelling older adults with mild-to-moderate depressive symptoms and chronic insomnia will be recruited.

Eligible participants will be randomized to health education control, Tai Chi or conventional exercise interventions on a 1:1:1 basis after baseline assessment.

All interventions will last for 3 months. Outcomes will be assessed at baseline, at 3 months and at 6 months after the completion of the intervention.

Being tested
Tai Chi, Conventional exercise, Health Education Control
Keywords
Exercise, Tai Chi, Elderly, Depression, Insomnia
Medical subject headings
Depression, Sleep Initiation and Maintenance Disorders, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tai ChiBehavioural

    The Tai Chi intervention will be prescribed as a 3-month program with two 1.5-h sessions weekly instructed by qualified Tai Chi instructors.

  • Conventional exerciseBehavioural

    The conventional exercise intervention will be prescribed as a 3-month program with two 1.5-h sessions of generic fitness training weekly instructed by qualified instructors.

  • Health Education ControlBehavioural

    Participants in the control group will participate in a health education program delivered by research personnel.

Study groups in NCT05482646
Study groupRoleWhat they receive
Tai ChiExperimentalThis group will perform 3 months of Tai Chi training
Receives: Behavioral: Tai Chi
Conventional exerciseActive comparatorThis group will perform 3 months of conventional exercise training
Receives: Behavioral: Conventional exercise
Health Education ControlOtherThis group will participate in a 3-month health education program
Receives: Behavioral: Health Education Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospital Anxiety and Depression Scale - Depression

    The depression score of the Hospital Anxiety and Depression Scale (HADS-D) will be used to evaluate the severity of depressive symptoms. This consists of a seven-item questionnaire with an overall score ranging from 0 to 21. Higher scores are indicative of more severe depressive symptoms.

    Measured: 3 months (post-intervention)

  2. Hospital Anxiety and Depression Scale - Depression

    The depression score of the Hospital Anxiety and Depression Scale (HADS-D) will be used to evaluate the severity of depressive symptoms. This consists of a seven-item questionnaire with an overall score ranging from 0 to 21. Higher scores are indicative of more severe depressive symptoms.

    Measured: 9 months (6 months post-intervention follow-up)

Secondary outcomes (20)
  1. Insomnia severity index

    The Insomnia Severity Index (ISI) will be used to assess perceived insomnia severity. It consists of a seven-item questionnaire with each item being rated from 0 to 4 on a Likert scale (total score range 0-28). Higher scores are representative of a more severe perception of insomnia.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  2. Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index (PSQI) will be used to assess subjective sleep quality. It consists of a 19-item questionnaire designed to measure sleep quality and disturbance. The 19 items are grouped into 7 components, and each component yields a score ranging from 0 to 3, with 3 indicating the greatest sleep dysfunction. The total score of the PSQI ranges from 0 to 21, with higher scores indicating worse sleep quality.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  3. Patient Health Questionnaire

    The Patient Health Questionnaire (PHQ-9) will be used to assess the severity of depression. The questionnaire is composed of 9 items, with each item being rated from 0 to 3. The PHQ-9 has a total score ranging from 0 to 27, with higher scores suggesting higher depressive symptom severity.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  4. General Anxiety Disorder Scale

    The General Anxiety Disorder Scale (GAD-7) will be used to assess the severity of anxiety. The GAD-7 is composed of 7 items, each being rated from 0 to 3 and with a total score range of 0-21. Higher scores are representative of greater anxiety symptoms.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  5. Hospital Anxiety and Depression Scale - Anxiety

    The anxiety score of the Hospital Anxiety and Depression Scale (HADS-A) will be used to assess the severity of anxiety symptoms. The HADS-A consists of a seven-item questionnaire with an overall score ranging from 0 to 21. Higher scores are indicative of greater anxiety symptoms.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  6. Medication usage

    The use of medications will be recorded.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  7. The 12-item Short Form Survey

    The 12-item Short Form Survey (SF-12) will be used to measure health-related quality of life. It consists of 12 items that are aggregated to form 2 summary scores: mental component score (MCS) and physical component score (PCS). Both MCS and PCS have a scoring range of 0 to 100, with higher scores indicating better mental and physical functioning.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  8. Short Physical Performance Battery

    The Short Physical Performance Battery (SPPB) will be used to assess physical function and balancing performance. The SPPB involves repeated timed chair stands and a 4-meter walk to measure gait speed. Scores ranging from 1 to 4 are assigned based on test results, with higher scores indicating better physical function and balance.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  9. Sleep efficiency through actigraph

    Sleep efficiency will be objectively evaluated by means of an actigraph. Sleep efficiency is the ratio between the time spent asleep and the total time spent in bed (expressed as %). Higher rates are indicative of healthier sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  10. Sleep efficiency through sleep diary

    Sleep efficiency will be subjectively evaluated by means of a sleep diary. Sleep efficiency is the ratio between the time spent asleep and the total time spent in bed (expressed as %). Higher rates are indicative of healthier sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  11. Wake time after sleep onset through actigraph

    Wake time after sleep onset will be objectively measured by means of an actigraph. It represents the total number of minutes that a person is awake after having initially fallen asleep (expressed as minutes). Higher values are indicative of more severe sleep problems.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  12. Wake time after sleep onset through sleep diary

    Wake time after sleep onset will be subjectively measured by means of a sleep diary. It represents the total number of minutes that a person is awake after having initially fallen asleep (expressed as minutes). Higher values are indicative of more severe sleep problems.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  13. Number of awakenings through actigraph

    The number of awakenings will be objectively measured by means of an actigraph. It represents the total number of times that the participant woke up throughout the night (expressed as N). Higher values indicate worse sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  14. Number of awakenings through sleep diary

    The number of awakenings will be subjectively measured by means of a sleep diary. It represents the total number of times that the participant woke up throughout the night (expressed as N). Higher values indicate worse sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  15. Sleep onset latency through actigraph

    Sleep onset latency will be objectively measured by means of an actigraph. It represents the time that it takes for a participant to fall asleep and is expressed in minutes. Higher values are indicative of worse sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  16. Sleep onset latency through sleep diary

    Sleep onset latency will be subjectively measured by means of a sleep diary. It represents the time that it takes for a participant to fall asleep and is expressed in minutes. Higher values are indicative of worse sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  17. Average awake time through actigraph

    Average awake time will be objectively measured by means of an actigraph. It is expressed as wake time after sleep onset divided by the number of awakenings, and is expressed in minutes. Higher values represent worse sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  18. Average awake time through sleep diary

    Average awake time will be subjectively measured by means of a sleep diary. It is expressed as wake time after sleep onset divided by the number of awakenings, and is expressed in minutes. Higher values represent worse sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  19. Total sleep time through actigraph

    Total sleep time will be objectively measured by means of an actigraph. It represents the total number of minutes spent asleep during the sleep period (expressed as minutes). Higher values are indicative of healthier sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

  20. Total sleep time through sleep diary

    Total sleep time will be subjectively measured by means of a sleep diary. It represents the total number of minutes spent asleep during the sleep period (expressed as minutes). Higher values are indicative of healthier sleep patterns.

    Measured: 3 months (post-intervention) and 9 months (6 months post-intervention follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2022
  2. Study start2 Aug 2022
  3. Primary completion28 Feb 2025
  4. Study completion28 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
420 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05482646
Sponsor's protocol ID
TaiChiTrialHKU2020
Status last verified
Mar 2025
First submitted
27 Jul 2022
Last updated
27 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Tai Chi and Conventional exercise in people with Depressive Symptoms and Chronic Insomnia, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospital Anxiety and Depression Scale - Depression (time frame: 3 months (post-intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in